Jeffrey Farricielli, MD
Physical Medicine & Rehabilitation · Mount Pleasant, SCNPI 1730315813
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 72.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $4,807 and has fallen 98.6% since, to $68 in 2025. Among physical medicine & rehabilitation clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $85.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Forte Bio-pharma LLC$758
- GRT US Holding, Inc.$176
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$75
- Protega Pharmaceutials Inc$75
- Biodelivery Sciences International, Inc.$75
- plus $534 from 15 others
What the payments were for
- Speaking & faculty fees$2,50040%
- Travel & lodging$1,71828%
- Food & beverage$1,99032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $4,516 |
| Forte Bio-pharma LLC | 8 | $758 |
| GRT US Holding, Inc. | 3 | $176 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $75 |
| Protega Pharmaceutials Inc | 1 | $75 |
| Biodelivery Sciences International, Inc. | 6 | $75 |
| Stimwave Technologies Incorporated | 1 | $68 |
| Collegium Pharmaceutical, Inc. | 4 | $58 |
| Nevro Corp. | 3 | $55 |
| Pfizer | 4 | $55 |
| Zyla Life Sciences, Inc. | 4 | $54 |
| Pacira Pharmaceuticals Incorporated | 3 | $50 |
| Orthogenrx Inc. | 3 | $47 |
| Kaleo, Inc. | 4 | $45 |
| Boston Scientific | 1 | $24 |
| Averitas Pharma Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Abbott | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $13 |
| Sentynl Therapeutics, Inc. | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,208 in reported general payments places this provider in the 90th percentile of 122 physical medicine & rehabilitation providers in South Carolina.
See all physical medicine & rehabilitation providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 61 | $53,182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 782 | $23,289 |
| OxycontinOxycodone Hcl | 34 | $19,548 |
| BelbucaBuprenorphine Hcl | 21 | $13,409 |
| OzempicSemaglutide | 14 | $12,805 |
| LicartDiclofenac Epolamine | 14 | $10,294 |
| Oxycodone Hcl | 427 | $9,551 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 246 | $6,679 |
| MovantikNaloxegol Oxalate | 15 | $6,265 |
| Buprenorphine | 30 | $5,039 |
| Diclofenac Sodium | 91 | $3,877 |
| Morphine Sulfate ErMorphine Sulfate | 138 | $3,269 |
| Lidocaine | 40 | $3,215 |
| Gabapentin | 171 | $1,648 |
| Lubiprostone | 20 | $1,647 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $58 | $66,59282 claims |
| Redhill Biopharma Inc.Movantik | $13 | $6,26515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 122 physical medicine & rehabilitation providers in South Carolina.
Other physical medicine & rehabilitation in Mount Pleasant
- Daniel NemethMount Pleasant$5K
- Kirstin WeiderMount Pleasant$2K
- William LorenzFlorence$66K
- Charles NivensBluffton$25K
- Jonathan ChapekisGreer$17K
- Rebecca HoldrenGreenville$15K
- Nancey TsaiHanahan$13K
- Ashley MaybinConway$10K
- Anthony AlexanderFlorence$10K
- Eleasa HulonGreenville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.